Voutsinas S, Wynne-Davies R
J Med Genet. 1983 Oct;20(5):345-9. doi: 10.1136/jmg.20.5.345.
The association of diaphyseal aclasis and neurofibromatosis with malignant neoplasms has been variously reported as between 5 and 28% of all cases, but malignant disease invariably presents at hospital and the true frequency from an unselected group is unknown. The current survey reviews not only hospital patients but also their affected relatives, with particular reference to malignant disease and the cause of death in all family members. A survey of 36 index patients and 80 known affected relatives with diaphyseal aclasis and 37 index patients and 33 known affected relatives with neurofibromatosis has been carried out. The observed proportions with associated malignant disease were 0.9% of all cases of diaphyseal aclasis and 4.3% of neurofibromatosis. The authors consider this is still too high an estimate in view of the number of persons in the families only mildly affected by the inherited disease who cannot be identified, although their malignant disease will be known. A more likely figure for malignant change in diaphyseal aclasis is calculated at 0.5% (or 1.3% of those over 21 years) and in neurofibromatosis 2.0% (or 4.2% of those over 21 years).
骨干性骨软骨瘤病和神经纤维瘤病与恶性肿瘤的关联在所有病例中的报道比例各不相同,介于5%至28%之间,但恶性疾病总是在医院中出现,来自未经过挑选的群体的真实发病率尚不清楚。本次调查不仅审查了住院患者,还审查了他们受影响的亲属,特别提及了所有家庭成员中的恶性疾病和死因。对36名患有骨干性骨软骨瘤病的索引患者和80名已知受影响的亲属,以及37名患有神经纤维瘤病的索引患者和33名已知受影响的亲属进行了调查。观察到的伴有恶性疾病的比例在所有骨干性骨软骨瘤病病例中为0.9%,在神经纤维瘤病中为4.3%。作者认为,鉴于家庭中仅有轻度遗传性疾病影响的人数无法确定,尽管他们的恶性疾病是已知的,但这个估计值仍然过高。骨干性骨软骨瘤病恶性变化的更可能数字计算为0.5%(或21岁以上者的1.3%),神经纤维瘤病为2.0%(或21岁以上者的4.2%)。